Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer
- PMID: 12453329
- DOI: 10.1016/S1533-0028(11)70495-9
Postmarketing re-evaluation of irinotecan plus 5-fluorouracil/leucovorin for first-line treatment of metastatic colorectal cancer
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
